ISCET

International Society for Clinical Eye Tracking

Details of Meeting 3 (2023-07-05)

Region: Europe/Africa

Date/time

Wednesday July 5th 2023 at 0700 PDT (US Pacific) / 1000 EDT (US East Coast) / 1500 BST (UK) / 1600 CEST (Central Europe) / 1930 IST (India).

Chaired by Valldeflors Viñuela Navarro (Universitat Politècnica de Catalunya).

Agenda

  • Welcome
  • Recap of ISCET progress so far (presented by Matt J Dunn)
  • Setting priorities for ISCET standards development. Based on:
    1. current use of clinical eye tracking internationally, i.e., what are the current main use cases? How can we clearly establish this?
    2. which patient groups would most benefit from standards.
  • Developing a mission statement for ISCET – e.g., to provide clinical guidance / represent the clinical eye tracking sector – anything else?
  • Any other business

Meeting recording

Attendees

12 people attended the meeting.

Notes

Understanding clinical use of eye trackers

  • Use of eye trackers in the following clinical disorders/disciplines was mentioned:
    • Eye movement disorders (e.g. nystagmus)
    • Concussion (lots of recent products being developed)
    • Neuropsychology
    • Dizziness
    • Orthoptics
    • Optometry
    • Reading disability
    • Audiology
    • Ophthalmology
    • Neuro-ophthalmology

However, this may not be an exhaustive list and further work is required to ensure no disciplines are excluded. Current ISCET membership may not reflect actual international use.

  • Could approach manufacturers to determine full extent of clinical eye tracker use
    • However, clinical uses are currently ‘off-label’ for many eye trackers so this may not reflect actual use
  • After identifying a list of clinical disciplines, ISCET could approach professional clinical bodies and ask a representative from each to attend a meeting to determine actual scope of usage and/or distribute a questionnaire to their members
    • Gemma Arblaster will determine whether University of Sheffield is able to provide ethical approval as host institution for a questionnaire study on current international eye tracker usage; results may be publishable.
    • Matt Dunn will create a collaborative document to enable members to propose suggestions for organisations to approach and questions to ask regarding eye tracker usage

Remit of ISCET

  • Suggested that ISCET add to its remit “maintainence of reference datasets” (i.e. ‘normative data’)
  • Unlikely that ISCET would want to be involved in signing people off as competent in techniques (too resource-intensive; providing guidance/standard protocols is enough)

Structure of ISCET

  • Moving toward a committee structure may be worthwhile
  • To be more inclusive of collegues in the Americas, a a third meeting time should be added, mirroring ISCEV’s structure of international representation. The three regions are therefore:
    • Europe/Africa
    • Asia/Australia
    • Americas
  • Noted that only 12 people in attendance at this meeting (compare to 70 at first meeting). Discussed:
    • Is it too difficult to sign up to the mailing list / find the website?
    • Is the time slot not amenable to clinicians?
    • Consider alternating the day of the week
    • Consider advertising via more channels and encouraging current members to spread the word (provide link to website and sign-up to mail group)

Next meeting

The next meeting will be arranged at a time to suit the Americas and will focus on:

  1. Identifying representative/professional clinical bodies to approach to (a) determine current international eye tracker usage and (b) expand ISCET membership
  2. Formalising committees for each of the three regions (Europe/Africa, Asia/Australia, Americas)
  3. Formalise ISCET’s purpose (currently three aims proposed):
    1. Maintain guidelines
    2. Maintain reference datasets
    3. Represent the clinical eye tracking sector

Chat

15:11:07  From Matt J Dunn : https://sites.google.com/view/clinicaleyetracking/meeting-2-2023-05-30

15:31:33  From Gemma Arblaster : Yes – it went to the British and Irish Orthoptic Society, but we could go out to the wider European and International Orthoptic Associations as well

15:42:10  From Gemma Arblaster : If we are keen to do this – I am happy to be part of a working group surveying clinical eye tracking use

15:49:54  From Matt J Dunn : Neurological disorders
    Nystagmus (many people)
    Antisaccades
    Saccadic reaction times
    Fixational eye movements
    Reading disability / dyslexia
    Orthoptics
    Ophthalmology
    Audiology
    Amblyopia
    Cognitive impairment
    Glaucoma
    Vergence / diplopia
    Neuropsychology

15:53:17  From Matt J Dunn : missing on the list: vestibular functions (VOR, head Impulse test, caloric Irrigation/Nystagmus, etc.)

16:03:21  From Jonathan Erichsen  To  Matt J Dunn(privately) : Lee has been warned that we’re running over.

16:05:15  From Mario E Giardini (University of Strathclyde, UK)  To  Matt J Dunn(privately) : Need to leave. Many thanks.

16:06:30  From Gemma Arblaster : good idea

16:07:45  From Matt J Dunn : https://sites.google.com/view/clinicaleyetracking/home

16:07:51  From Matt J Dunn : https://www.jiscmail.ac.uk/cgi-bin/webadmin?A0=ISCET

16:10:16  From Gemma Arblaster : Thanks all – I’ve got to go now too.